The Vanguard Group buys a big stake in Boston Scientific as BlackRock expands its holdings in the medical device company. Count mutual fund giant Vanguard Group and hedge fund BlackRock Inc. among the believers in the comeback story at Boston Scientific (NYSE:BSX). Vanguard took up a 6.7% stake in Boston Scientific as of the end of last year, according to regulatory filings, after a year that saw BSX shares rise more than 105%, to $12.02 apiece, from their $5.86 opening Jan. 2, 2013.
Help employers find you! Check out all the jobs and post your resume.
